You are required to be logged in to access the full website
Click here if you have forgotten your username or password
22 January 2026 - NeuroSense Therapeutics Ltd (NASDAQ:NRSN), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, announced on Wednesday that the United States Patent and Trademark Office has ...
22 January 2026 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq: ATOS) announced on Wednesday that The Healthcare Technology Report has recognized the company's founder, chairman, president, and chief executive officer...
21 January 2026 - US clinical-stage biopharmaceutical company Actuate Therapeutics Inc (NASDAQ:ACTU) on Wednesday announced plans to initiate a Phase 1/2 clinical program evaluating its oral elraglusib tablet in patients with advanced cancers.The Pha...
21 January 2026 - Ionis Pharmaceuticals Inc (Nasdaq:IONS), a US-based provider of RNA-targeted medicines, and Japanese healthcare company Otsuka Pharmaceutical Co Ltd on Wednesday announced that the European Commission has approved DAWNZERA (donidalo...
21 January 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) announced on Wednesday that it has entered into a collaboration with Gazi University Faculty of Medicine in Türkiye to support ra...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe